Latest 8-K filings

MARA Holdings, Inc. announced the appointment of Craig Hart and Nancy Novak to its board of directors, effective August 1, 2026, as part of a planned transition.

Harmony Biosciences announced record Q2 2026 revenue of $261.3 million, a 30% year-over-year increase, and presented encouraging clinical data for its orexin-2 agonist BP-205.

Rani Therapeutics Holdings, Inc. announced the appointment of Michelle Gilson to its Board of Directors and as chair of the Audit Committee, effective August 1, 2026.

Sysco Corporation announced robust financial results for its fourth fiscal quarter and full year 2026, exceeding guidance and providing optimistic projections for fiscal year 2027.

W.W. Grainger, Inc. announced robust second quarter 2026 financial results, exceeding expectations with significant sales growth and earnings per share increase, leading to an improved full-year outlook.

Exagen Inc. announced record revenue and test volumes for Q2 2026, alongside a reduced net loss and increased full-year revenue guidance.

Reservoir Media announced first quarter fiscal 2027 results, showcasing 12% year-over-year revenue growth driven by strong performance in both publishing and recorded music segments.

Portillo's Inc. announced the appointment of Kevin Kalicak as its new Chief Financial Officer and Treasurer, effective September 7, 2026, bringing extensive restaurant industry financial experience.

IPG Photonics announced second quarter 2026 financial results, showcasing an 11% year-over-year revenue increase driven by robust Industrial Solutions demand.

TPG Inc. announced strong second quarter 2026 results, highlighting record performance for the first half of the year with significant growth in Assets Under Management and Fee-Related Earnings.

RE/MAX Holdings and The Real Brokerage Inc. announced the deadline for RE/MAX Class A common stockholders to elect their merger consideration, with August 18, 2026, as the key date for record holders.

Central Bancompany, Inc. announced robust second quarter 2026 financial results, including a 24.5% year-over-year increase in net income, and authorized a new $100 million stock repurchase program.

Broadridge Financial Solutions announced strong fourth quarter and fiscal year 2026 results, highlighted by 8% recurring revenue growth, a 12% increase in Adjusted EPS, and a 12% dividend hike.

Cummins Inc. announced record second-quarter 2026 revenues of $9.5 billion and raised its full-year revenue and EBITDA guidance, driven by strong demand in key markets.

CervoMed Inc. announced its drug candidate neflamapimod has received an Innovation Passport under the UK's Innovative Licensing and Access Pathway (ILAP) for the treatment of Dementia with Lewy Bodies (DLB).

Galectin Therapeutics Inc. announced the conversion of approximately $105.8 million in debt, including principal and accrued interest, into common stock by Chairman Richard E. Uihlein, significantly strengthening its balance sheet.

Rhythm Pharmaceuticals announced robust second quarter 2026 financial results, driven by strong IMCIVREE sales and encouraging preliminary data from its RM-718 Phase 2 trial.

American Express Global Business Travel (GBTG) announced robust second quarter 2026 financial results, driven by a 38% increase in revenue and significant growth in Adjusted EBITDA.

McDonald's Corporation announced the appointment of Skye Anderson as President of McDonald's USA, succeeding Joe Erlinger, effective August 4, 2026.

Energy Transfer LP announced robust second quarter 2026 financial results, showcasing significant year-over-year growth in net income, Adjusted EBITDA, and Distributable Cash Flow, alongside an upward revision of full-year financial guidance.

Ball Corporation announced robust second quarter 2026 financial results, showcasing significant year-over-year increases in earnings per share and operating earnings, alongside a 4.3% rise in global aluminum packaging shipments.

Faeth Therapeutics announced its second quarter 2026 financial results, detailing progress in its PIKTOR clinical trials for endometrial and breast cancer, alongside a substantial increase in cash reserves.

Zebra Technologies announced record second-quarter 2026 results with a 20.4% year-over-year net sales increase and raised its full-year outlook.

SunocoCorp LLC announced robust second quarter 2026 financial and operating results, highlighted by substantial increases in net income and Adjusted EBITDA, leading to an upward revision of full-year guidance.

Cipher Digital Inc. announced Q2 2026 results, highlighting accelerated delivery of Black Pearl data center capacity, acquisition of a 900 MW site option near San Antonio, and successful funding for its Stingray development.

Sunoco LP announced robust second quarter 2026 financial and operating results, highlighted by substantial increases in net income, Adjusted EBITDA, and distributable cash flow, leading to an upward revision of full-year guidance.

Fidelity National Information Services (FIS) announced robust second quarter 2026 financial results, showcasing significant revenue and adjusted EPS growth, alongside a substantial increase in free cash flow.

ImmunityBio announced record Q2 2026 net product revenue of $50.7 million, up 92% year-over-year, alongside significant progress in its clinical pipeline and regulatory milestones.

Hillman Solutions Corp. reported strong Q2 2026 results, with net sales up 9.8%, and announced a $315 million acquisition of Kanebridge Corp. to expand its industrial distribution presence.

Sharon AI Holdings Inc. announced a substantial five-year, US$373 million AI cloud service agreement, significantly expanding its contracted capacity and reinforcing its position in the Asia-Pacific AI infrastructure market.